.Pharmacolibrary.Drugs.C_CardiovascularSystem.C04A_PeripheralVasodilators.C04AX10_Moxisylyte.Moxisylyte .Pharmacolibrary.Drugs.C_CardiovascularSystem.C04A_PeripheralVasodilators.C04AX10_Moxisylyte.Moxisylyte| name: | Moxisylyte | |
| ATC code: | C04AX10 | route: | oral |
| compartments: | 1 | |
| dosage: | 40 | mg |
| volume of distribution: | 2.5 | L |
| clearance: | 70 | L/h |
| other parameters in model implementation | ||
Moxisylyte (also known as thymoxamine) is an alpha-adrenergic antagonist formerly used to treat peripheral vascular diseases such as Raynaud's phenomenon and erectile dysfunction by causing vasodilation. It is not widely approved or used in current clinical practice.
Estimated pharmacokinetic parameters for a typical adult patient, as published data are not available.